BRIANA HODGE: Open Payments
NPI 1174384697 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 38 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $929 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $136 |
| TG Therapeutics, Inc. | 1 | $127 |
| ABBVIE INC. | 5 | $87 |
| Amgen Inc. | 3 | $63 |
| BETA BIONICS, INC. | 5 | $53 |
| Novo Nordisk Inc | 3 | $50 |
| Ascendis Pharma Endocrinology Inc | 1 | $28 |
| Amneal Pharmaceuticals LLC | 1 | $28 |
| Abbott Laboratories | 1 | $27 |
| Amphastar Pharmaceuticals, Inc. | 1 | $22 |
Products named: JARDIANCE, BRIUMVI, TEPEZZA, UBRELVY, iLet Bionic Pancreas, Ozempic, SYNTHROID, Yorvipath.
Industry payments across NY — which companies pay providers there.
